451 / 1851
Time after treatment (months)
0 6 12 18 24 30 36 42 48 54 60
Cancer specific survival (%)
0
20
40
60
80
100
p=0.01
multivariate p= 0.02
65%
53%
DAHANCA 10
Aranesp
Control
02
Hazard ratio
1.41
(1.08-1.85)
Overgaard et al ICHNO 2013
DAHANCA 10 – Cancer-specific and overall survival